Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bristol Myers Squibb said its experimental cell therapy arlocabtagene autoleucel (arlo-cel) met the main goal in a mid-stage trial in patients with a hard-to-treat form of multiple myeloma.
BMY said its experimental cell therapy met the main goal of a mid-stage trial.